Fennec Pharmaceuticals (TSX:FRX) Change In Inventory : C$-2.13 Mil (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Fennec Pharmaceuticals Change In Inventory?

Fennec Pharmaceuticals's change in inventory for the quarter that ended in Dec. 2023 was C$-0.54 Mil. It means Fennec Pharmaceuticals's inventory increased by C$0.54 Mil from Sep. 2023 to Dec. 2023 .

Fennec Pharmaceuticals's change in inventory for the fiscal year that ended in Dec. 2023 was C$-2.12 Mil. It means Fennec Pharmaceuticals's inventory increased by C$2.12 Mil from Dec. 2022 to Dec. 2023 .

Fennec Pharmaceuticals's Total Inventories for the quarter that ended in Dec. 2023 was C$2.89 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Fennec Pharmaceuticals's Days Inventory for the quarter that ended in Dec. 2023 was 261.49.

Inventory Turnover measures how fast the company turns over its inventory within a year. Fennec Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.35.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Fennec Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.20.

Fennec Pharmaceuticals Change In Inventory Historical Data

The historical data trend for Fennec Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fennec Pharmaceuticals Change In Inventory Chart

Fennec Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-0.78

-2.12

Fennec Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-	-0.47	-0.69	-0.43	-0.54

Fennec Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.13 Mil.

Fennec Pharmaceuticals (TSX:FRX) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Fennec Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	2.6335	/	0.919	*	365 / 4
	=	261.49

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Fennec Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.919	/	2.6335
	=	0.35

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Fennec Pharmaceuticals's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	2.6335	/	13.06
	=	0.20

Fennec Pharmaceuticals Change In Inventory Related Terms

Thank you for viewing the detailed overview of Fennec Pharmaceuticals's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Fennec Pharmaceuticals (TSX:FRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fennec Pharmaceuticals Inc (TSX:FRX) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

FENC:USA RV41:Germany

Address

68 TW Alexander Drive, PO Box 13628, Research Triangle Park, NC, USA, 27709

Website

https://www.fennecpharma.com

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. The company principally operates in the United States.